NR4A1 and cancer: Examples are the GnRH-III peptide conjugates with doxorubicin, which enhance selectivity against hormone receptor-positive cancer types [23], while oligoarginine peptides facilitate faster cellular uptake of chemotherapeutic agents, thus increasing their effectiveness [25,26,27].